Altmetrics
Downloads
233
Views
158
Comments
0
A peer-reviewed article of this preprint also exists.
Submitted:
19 May 2023
Posted:
22 May 2023
You are already at the latest version
GMO and Environmental Safety | Frequency and Percent (%) | ||||
---|---|---|---|---|---|
Classification statements | Worse | Neither better nor worse | Better | Not sure | No Answer |
Increased herbicide uses | 4 (14%) | 7 (25%) | 8 (29%) | 6 (21%) | 3 (11%) |
Development of Herbicide-ResistantWeeds “super weeds” | 7 (25%) | 7 (25%) | 4 (14%) | 7 (25%) | 3 (11%) |
Development of Insect-Resistant Crops “Super bugs” | 6 (21%) | 6 (21%) | 6 (21%) | 7 (25%) | 3 (11%) |
Contamination due to gene flow from GM crops to wild and weedy crop relatives, non-GM crops and foods | 10 (36%) | 6 (21%) | 2 (7%) | 7 (25%) | 3 (11%) |
Biodiversity loss | 9 (32%) | 7 (25%) | 3 (11%) | 6 (21%) | 3 (11%) |
Ethics and GMO | Frequency and percent (%) | ||||
---|---|---|---|---|---|
Classification statements | Worse | Neither better nor worse | Better | Not sure | No Answer |
Potential harm to human health | 8 (29%) | 9 (32%) | 3 (11%) | 3 (11%) | 5 (18%) |
Potential harm to environment | 10 (36%) | 7 (25%) | 3 (11%) | 4 (14%) | 4 (14%) |
Negative impact on traditional farming practices | 10 (36%) | 6 (21%) | 3 (11%) | 4 (14%) | 5 (18%) |
Excessive Corporate dominance | 11 (39%) | 7 (25%) | 1 (4%) | 4 (14%) | 5 (18%) |
“Unnaturalness” of technology | 7 (25%) | 9 (32%) | 2 (7%) | 5 (18%) | 5 (18%) |
Perceptions on GMOs | Respondents feedback (YES vs No) | Frequency (N) |
Percent (%) |
---|---|---|---|
Are GMOs safe? | Yes | 18 | 64 |
No | 10 | 36 | |
Are GMOs perceived differently from traditional foods? | Yes | 26 | 93 |
No | 2 | 7 | |
Are there known main issues of concern for human health? | Yes | 16 | 57 |
No | 12 | 43 | |
Are there implications for farmers if they turn to GMOs crop production? | Yes | 24 | 86 |
No | 4 | 14 |
Variables | Correct Percent (%) |
Incorrect Percent (%) |
---|---|---|
Antibiotic resistance occurs when your body becomes resistant to antibiotics and they no longer work as well | 52 | 48 |
Many infections are becoming increasingly resistant to treatment by antibiotics | 93 | 7 |
If bacteria are resistant to antibiotics, it can be very difficult or impossible to treat the infections they cause | 100 | 0 |
Antibiotic resistance is an issue that could affect me or my family | 100 | 0 |
Antibiotic resistance is an issue in other countries but not here | 96 | 4 |
Antibiotic resistance is only a problem for people who take antibiotics regularly | 93 | 7 |
Bacteria which are resistant to antibiotics can be spread from person to person | 96 | 4 |
Antibiotic-resistant infections could make medical procedures like surgery, organ transplants and cancer treatment much more dangerous | 100 | 0 |
Antibiotic-resistant bacteria can spread from animals to animal products people eat, such as chicken and meat | 93 | 7 |
Antibiotic-resistant bacteria can spread from animals to crop produce, such as fruits and vegetables, through unclean water or soil | 89 | 11 |
Antibiotic-resistant bacteria can spread from animals to the environment, through animal faeces. | 96 | 4 |
You can become sick with bacterial infections that are resistant to antibiotics if eat food that's been infected with antibiotic-resistant bacteria and not properly prepared or cooked. | 93 | 7 |
You can become sick with bacterial infections that are resistant to antibiotics if handle unclean animals and don't wash your hands. | 93 | 7 |
You can become sick with bacterial infections that are resistant to antibiotics if touch or use unclean surfaces and don't wash your hands or clean surfaces. | 85 | 15 |
Antibiotics widely used in the country for food production. | 96 | 4 |
Variables | Range | Mean | SD | Min | Max |
---|---|---|---|---|---|
Knowledge | |||||
Knowledge scores | 0-15 | 13.74 | 1.35 | 10 | 15 |
Attitudes | |||||
Perceived risk to farmers | 1-5 | 1.85 | 1.06 | 1 | 5 |
Perceived risk of misuse | |||||
Use of antibiotics to prevent diseases | 1-5 | 3.89 | 1.34 | 1 | 5 |
Use of antibiotics to enhance growth | 1-5 | 3.37 | 1.47 | 1 | 5 |
Use of antibiotics as therapy | 1-5 | 3.33 | 1.41 | 1 | 5 |
Use of antibiotics in food to treat clinical diseases | 1-5 | 3.15 | 1.20 | 1 | 5 |
Practices | |||||
People should use antibiotics only when they are prescribed by a vet doctor | 1-3 | 1.30 | 0.72 | 1 | 3 |
Farmers should give fewer antibiotics to food-producing animals | 1-3 | 1.37 | 0.79 | 1 | 3 |
People should not keep antibiotics and use them later for other livestock diseases | 1-3 | 1.11 | 0.42 | 1 | 3 |
Governments should reward the development of new antibiotics | 1-3 | 1.56 | 0.80 | 1 | 3 |
Pharmaceutical companies should develop new antibiotics | 1-3 | 1.52 | 0.85 | 1 | 3 |
Antibiotic resistance is one of the biggest problems the world faces | 1-3 | 1.07 | 0.27 | 1 | 2 |
Medical experts will solve the problem of antibiotic resistance before it becomes too serious | 1-3 | 2.33 | 0.68 | 1 | 3 |
Everyone needs to take responsibility for using antibiotics responsibly | 1-3 | 1.00 | 0.00 | 1 | 1 |
There is not much people like me can do to stop antibiotic resistance | 1-3 | 2.96 | 0.19 | 2 | 3 |
I am worried about the impact that antibiotic resistance will have on my health, and that of my family | 1-3 | 1.00 | 0.00 | 1 | 1 |
I am not at risk of getting an antibiotic resistant infection, as long as I take my antibiotics correctly. | 1-3 | 2.74 | 0.66 | 1 | 3 |
Statement raising awareness on AMR risks | Frequency | Percent (%) |
---|---|---|
1. Statement raising AMR risks in human health | ||
No significant awareness-raising activities on antibiotic resistance | 3 | 11.11 |
Some activities in parts of the country to raise awareness about risks of antibiotic resistance and actions that can be taken to address it | 7 | 25.93 |
Limited or small-scale antibiotic resistance awareness campaign targeting some, but not all, relevant stakeholders (e.g., general public, pharmacists, nurses, medicine sellers) | 15 | 55.56 |
Nationwide, government-supported antibiotic awareness campaign targeting all or the majority of stakeholders. | 2 | 7.41 |
2. Statement raising AMR risks in other sectors like Veterinary | ||
No significant awareness-raising activities on relevant aspects of risks of antimicrobial resistance | 6 | 22.22 |
Some activities in parts of the country to raise awareness about risks of antimicrobial resistance and actions that can be taken to address it. | 7 | 25.93 |
Limited or small-scale antimicrobial resistance awareness campaign targeting some but not all relevant stakeholders within sector. | 11 | 40.74 |
Nationwide, government-supported antimicrobial resistance awareness campaign targeting all or the majority of relevant stakeholders within sector. | 2 | 7.41 |
Focused, national scale government supported activities implemented to change behavior of relevant stakeholders within sector, with monitoring undertaken of their awareness and behavior change over last 2-5 years | 1 | 3.7 |
Reduction of AMR by Sanitation | Frequency | Percent (%) |
---|---|---|
No responses | 2 | 7.41 |
A national Infection prevention and control (IPC) programme or operational plan is available. National IPC and water, sanitation and hygiene (WASH) and environmental health standards exist but are not fully implemented. | 19 | 70.37 |
A national IPC programme and operational plan are available and national guidelines for health care IPC are available and disseminated. Selected health facilities are implementing the guidelines, with monitoring and feedback in place | 3 | 11.11 |
National IPC programme available according to the WHO IPC core components guidelines and IPC plans and guidelines implemented nationwide. All health care facilities have a functional built environment (including water and sanitation), and necessary materials and equipment to perform IPC, per national standards. | 3 | 11.11 |
Optimizing antimicrobial use | Frequency | Percent (%) |
---|---|---|
1. Statement on optimizing AMR use in human health sector | ||
No response | 3 | 11.11 |
No/weak national policy & regulations for appropriate use. | 5 | 18.52 |
National policy for antimicrobial governance and regulation developed for the community and health care settings | 7 | 25.93 |
Practices to assure appropriate antimicrobial use being implemented in some healthcare facilities and guidelines for appropriate use of antimicrobials available | 10 | 37.04 |
Guidelines and other practices to enable appropriate use are implemented in most health facilities nationwide. Monitoring and surveillance results are used to inform action and to update treatment guidelines and essential medicines lists. | 2 | 7.41 |
2. Statement on optimizing AMR use in animal and plant health sector | ||
No response | 1 | 3.7 |
No national policy or legislation regarding the quality, safety and efficacy of antimicrobial products, and their distribution, sale or use. | 4 | 14.81 |
National legislation covers some aspects of national manufacture, import, marketing authorization, control of safety, quality and efficacy and distribution of antimicrobial products. | 13 | 48.15 |
National legislation covers all aspects of national manufacture, import, marketing authorization, control of safety, quality and efficacy and distribution of antimicrobial products | 5 | 18.52 |
Guidelines for responsible and prudent use of antimicrobials based on international standards (e.g., OIE Terrestrial and Aquatic Codes, Codex Alimentarius) are available according to animal species and/or production sector and include restriction of specific antimicrobial classes listed as Critically Important for humans and animals. | 4 | 14.81 |
Source of Information | Percent Cases GMO (%) |
Sectors for AMR (%) |
Percent (%) |
---|---|---|---|
School/college | 71.4 | Human Health | 11.1 |
Media (newspaper, TV, radio) | 64.3 | Animal Health | 48.2 |
Specific campaign | 35.7 | Plant Health | 14.8 |
Family member or friend | 17.9 | Food Production | 22.2 |
Extension worker | 17.9 | Food Safety | 29.6 |
Others (workshops, projects) | 17.9 | ||
Agrovet shop | 10.7 | ||
Can’t remember | 3.6 |
Safety of GMO | Frequency (percent %) | ||||
---|---|---|---|---|---|
Classification statements | Worse | Neither better nor worse | Better | Not sure | No Answer |
Transfer of antibiotic resistance | 4 (14%) | 11 (39%) | 4 (14 %) | 6 (22%) | 3 (11%) |
Transfer of toxicity | 4 (14%) | 12 (43%) | 2 (7%) | 2 (25%) | 3 (11%) |
Transfer of allergenicity | 7 (25%) | 10 (36%) | 2 (7%) | 6 (21%) | 3 (11%) |
Can cause cancer | 6 (21%) | 10 (36%) | 2 (7%) | 6 (21%) | 4 (15%) |
Immune suppression | 4 (14%) | 1 (43%) | 3 (7%) | 6 (21%) | 4 (14%) |
Loss of nutrition | 4 (14%) | 9 (32%) | 5 (19%) | 6 (21%) | 4 (14%) |
Ethical arguments on GMO | Frequency and percent (%) | ||||
---|---|---|---|---|---|
Classification statements | Strongly Agree | Agree | Neither agree Nor disagree | Disagree | Strongly disagree |
GM technology is against my belief/religion. | 2 (7%) | 2 (7%) | 10 (36%) | 7 (25%) | 7 (25%) |
By using GM technology, we are “playing God”. | 4 (14%) | 2 (7%) | 8 (29%) | 6 (21%) | 8 (29%) |
GM technology is not acceptable in animal production due to animal welfare concerns. | 2 (7%) | 5 (18%) | 9 (32%) | 4 (14%) | 8 (29%) |
GM technology is not ethically acceptable in food production. | 1 (4%) | 6 (21%) | 6 (21%) | 8 (29%) | 7 (25%) |
GM technology is not an ethically acceptable method for producing animal feed. | 1 (3%) | 7 (25%) | 7 (25%) | 5 (18%) | 8 (29%) |
GM technology is not an ethically acceptable method for medicine production. | 0 (0%) | 3 (11%) | 6 (21%) | 7 (25%) | 12 (43%) |
Using GM technology is "tampering" with nature i.e., “unnaturalness”. | 5 (18%) | 6 (21%) | 6 (21%) | 5(19%) | 6 (21%) |
GM technology is unnatural, and hence not acceptable. | 4 (14 %) | 2 (7%) | 8 (29%) | 7 (25%) | 7 (25%) |
Statement on support for GMOs | Strongly agree | Agree | Neither agree nor disagree | Disagree | Strongly disagree |
---|---|---|---|---|---|
Production of cheaper food. | 6 (21%) | 11 (39%) | 6 (21%) | 1 (5%) | 4 (14%) |
Saving human lives (e.g., by producing medicines and vaccines). | 10 (36%) | 15 (53%) | 2 (7%) | 1 (4%) | 0 (0%) |
More sustainable meat production using farmed animals (e.g., more efficient production and less animal disease). | 5 (18%) | 9 (32%) | 9 (32%) | 4 (14%) | 1 (4%) |
Production of animal feed (e.g., from plants, algae and microorganisms) | 7 (25%) | 10 (36%) | 7 (25%) | 3 (10%) | 1 (4%) |
Production of non-feed (e.g., cotton and fabrics, cosmetics). | 12 (43%) | 8 (29%) | 4 (14%) | 3 (10%) | 1 (4%) |
Production of vaccines (GM and DNA vaccine) to prevent disease. | 13 (46%) | 9 (32%) | 5 (18%) | 0 (0%) | 1 (4%) |
Awareness and understanding of Antibiotic resistance risks | Percent (%) |
---|---|
No significant awareness-raising activities on antibiotic resistance. | 11.1 |
Some activities in parts of the country to raise awareness about risks of antibiotic resistance and actions that can be taken to address it | 25.9 |
Limited or small-scale antibiotic resistance awareness campaign targeting some, but not all, relevant stakeholders (e.g., general public, pharmacists, nurses, medicine sellers) | 55.6 |
Nationwide, government-supported antibiotic awareness campaign targeting all or the majority of stakeholders | 7.4 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated